Optimization of parameters for preparation of docetaxel-loaded PLGA nanoparticles by nanoprecipitation method

Journal of Huazhong University of Science and Technology - Medical Science

Volumn 33, Issue 5, 2013, Pages 754-758

  Shi, Wei ^a   Zhang, Zhan Jie ^a   Yuan, Yin ^a   Xing, En Ming ^a   Qin, You ^a   Peng, Zhen Jun ^a   Zhang, Zhi Ping ^b   Yang, Kun Yu ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

cancer; docetaxel; nanoparticles; optimization; poly (lactide co glycolide)

Indexed keywords

ACETONE; ALCOHOL; ANTINEOPLASTIC AGENT; DOCETAXEL; LACTIC ACID; MACROGOL DERIVATIVE; NANOPARTICLE; POLYGLYCOLIC ACID; POLYLACTIC ACID POLYGLYCOLIC ACID COPOLYMER; POLYLACTIC ACID-POLYGLYCOLIC ACID COPOLYMER; SUCCINIC ACID DERIVATIVE; TAXOID;

ARTICLE; CHEMISTRY; DRUG FORMULATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; METHODOLOGY; NANOTECHNOLOGY; PARTICLE SIZE; PRECIPITATION; SCANNING ELECTRON MICROSCOPY; SURFACE PROPERTY; ULTRASTRUCTURE;

ACETONE; ANTINEOPLASTIC AGENTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG COMPOUNDING; ETHANOL; FRACTIONAL PRECIPITATION; LACTIC ACID; MICROSCOPY, ELECTRON, SCANNING; NANOPARTICLES; NANOTECHNOLOGY; PARTICLE SIZE; POLYETHYLENE GLYCOLS; POLYGLYCOLIC ACID; SUCCINATES; SURFACE PROPERTIES; TAXOIDS;

EID: 84886306203     PISSN: 16720733     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11596-013-1192-x     Document Type: Article

References (32)

1. Petrioli R, Pozzessere D, Messinese S, et al. Weekly low-dose docetaxel in advanced non-small cell lung cancer previously treated with two chemotherapy regimens. Lung Cancer, 2003,39(1):85-89
2. Coleman RE, Howell A, Eggleton SP, et al. Phase II study of docetaxel in patients with liver metastases from breast cancer. Ann Oncol, 2000,11(5):541-546
3. Glisson BS, Murphy BA, Frenette G, et al. Phase II trial of docetaxel and cisplatin combination chemotherapy in patients with squamous cell carcinoma of the head and neck. J Clin Oncol, 2002,20(6):1593-1599
4. Rowinsky EK. The development and clinical utility of the taxane class of antimicrotubule chemotherapy agents. Annu Rev Med, 1997,48:353-374
5. Weiss RB, Donehower RC, Wiernik PH, et al. Hypersensitivity reactions from Taxol. J Clin Oncol, 1990,8(7):1263-1268
6. Chu CY, Yang CH, Yang CY, et al. Fixed erythrodysaesthesia plaque due to intravenous injection of docetaxel. Br J Dermatol, 2000,142(4):808-811
7. Lavelle F, Bissery MC, Combeau C, et al. Preclinical evaluation of docetaxel (Taxotere). Semin Oncol, 1995,22(2 Suppl 4):3-16
8. Xu Z, Chen L, Gu W, et al. The performance of docetaxel-loaded solid lipid nanoparticles targeted to hepatocellular carcinoma. Biomaterials, 2009,30(2):226-232
9. Farokhzad OC, Langer R. Impact of nanotechnology on drug delivery. ACS Nano, 2009,3(1):16-20
10. Haley B, Frenkel E. Nanoparticles for drug delivery in cancer treatment. Urol Oncol, 2008,26(1):57-64
11. Saha RN, Vasanthakumar S, Bende G, et al. Nanoparticulate drug delivery systems for cancer chemotherapy. Mol Membr Biol, 2010,27(7):215-231
12. Bennis S, Chapey C, Couvreur P, et al. Enhanced cytotoxicity of doxorubicin encapsulated in polyisohexylcy-anoacrylate nanospheres against multidrug-resistant cells in culture. Eur J Cancer, 1994,30A(1):89-93
13. Magenheim B, Benita S. Nanoparticle characterization: a comprehensive physicochemical approach. STP Pharm Sci, 1991,1:221-241
14. Shive MS, Anderson JM. Biodegradation and biocompatibility of PLA and PLGA microspheres. Adv Drug Deliv Rev, 1997,28(1):5-24
15. Gan CW, Feng SS. Transferrin-conjugated nanoparticles of poly (lactide)-D-alpha-tocopheryl polyethylene glycol succinate diblock copolymer for targeted drug delivery across the blood-brain barrier. Biomaterials, 2010,31(30):7748-7757
16. Zhang Z, Mei L, Feng SS. Vitamin E D-alpha-tocopheryl polyethylene glycol 1000 succinate-based nanomedicine. Nanomedicine (Lond), 2012,7(11):1645-1647
17. Saxena V, Hussain MD. Inhibition of P-glycoprotein by D-alpha-tocopheryl polyethylene glycol 1000 succinate (TPGS). J Biomed Nanotechnol, 2013,9(7):1146-1154
18. Varma MV, Panchagnula R. Enhanced oral paclitaxel absorption with vitamin E-TPGS: effect on solubility and permeability in vitro, in situ and in vivo. Eur J Pharm Sci, 2005,25(4-5):445-453
19. Collnot EM, Baldes C, Schaefer UF. Vitamin E TPGS p-glycoprotein inhibition mechanism: influence on conformational flexibility, intracellular ATP levels, and role of time and site of access. Mol Pharm, 2010,7(3):642-651
20. Zhang Z, Lee SH, Gan CW, et al. In vitro and in vivo investigation on PLA-TPGS nanoparticles for controlled and sustained small molecule chemotherapy. Pharm Res, 2008,25(8):1925-1935
21. Prashant C, Dipak M, Yang CT, et al. Superparamagnetic iron oxide-loaded poly (lactic acid)-D-alpha-tocopherol polyethylene glycol 1000 succinate copolymer nanoparticles as MRI contrast agent. Biomaterials, 2010,31(21):5588-5597
22. Win KY, Feng SS. In vitro and in vivo studies on vitamin E TPGS-emulsified poly(D,L-lacticcoglycolid acid) nanoparticles for paclitaxel formulation. Biomaterials, 2006, 27(10):2285-2291
23. Barichello JM, Morishita M, Takayama K, et al. Encapsulation of hydrophilic and lipophilic drugs in PLGA nanoparticles by the nanoprecipitation method. Drug Dev Ind Pharm, 1999,25(4):471-476
24. Dong Y, Feng SS. Methoxyl poly(ethylene glycol)poly-(lactide) (MPEG-PLA) nanoparticles for controlled delivery of anticancer drugs. Biomaterials, 2004,25(14):2843-2849
25. Zhang Z, Feng SS. Nanoparticles of poly (lactide)/Vitamin E TPGS copolymer for cancer chemotherapy: synthesis, formulation, characterization and in vitro drug release. Biomaterials, 2006,27(2):262-270
26. Mu L, Feng SS. A novel controlled release formulation for the anticancer drug paclitaxel (Taxol): PLGA nanoparticles containing vitamin E TPGS. J Control Release, 2003,86(1):33-48
27. Mu L, Feng SS. Vitamin E TPGS used as emulsifier in the solvent evaporation/extraction technique for fabrication of polymeric nanospheres for controlled release of paclitaxel (Taxol). J Control Release, 2002,80(1-3):129-144
28. Kakran M, Sahoo NG, Antipina MN, et al. Modified supercritical antisolvent method with enhanced mass transfer to fabricate drug nanoparticles. Mater Sci Eng C Mater Biol Appl, 2013,33(5):2864-2870
29. Song X, Zhao Y, Hou S, et al. Dual agents loaded PLGA nanoparticles: Systematic study of particle size and drug entrapment efficiency. Eur J Pharm Biopharm, 2008,69(2):445-453
30. Lamprecht A, Ubrich N, Hombreiro Pérez M, et al. Influences of process parameters on nanoparticle preparation performed by a double emission pressure homogenization technique. Int J Pharm, 2000,196(2):177-182
31. Zhao L, Feng SS. Enhanced oral bioavailability of paclitaxel formulated in vitamin E-TPGS emulsified nanopart icles of biodegradable polymers: in vitro and in vivo studies. J Pharm Sci, 2010, 99(8):3552-3560
32. Zhang Z, Feng SS. Nanoparticles of poly (lacide)/vitamin E TPGS copolymer for cancer chemotherapy: synthesis, formulation, characterization and in vitro drug release. Biomaterials, 2006,27(2):262-270